The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...
Zacks.com on MSN13d
Henry Schein Stock to Gain From New Acquisitions Amid Macro WoesHenry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic ...
Henry Schein (Nasdaq: HSIC) announced today that it completed the acquisition of substantially all the assets of Acentus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback